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Cervical Cancer

Mary Elizabeth Jedlicka, RN, BSN, CCRN
Otterbein University, Westerville, Ohio
Introduction
According to the latest statistics from
the American Cancer Society, 11,995
women were diagnosed with cervical
cancer in 2013 and 4,217 women died from
this cancer (American Cancer Society,
2016). It is a disease that most often occurs
in women over 30, and the Center for
Disease Control (2016) estimates there are
more than 13,000 new diagnoses each
year. Scientists have been able to target
the reason for this disease to a virus called
the human papillomavirus. Unlike other
reproductive cancers, cervical cancer is the
only reproductive cancer that has screening
available to detect the early stages of
cellular change in a female’s cervix that can
lead to cancer; however, not all forms of
cervical cancer can be detected through
yearly PAP smear tests and HPV screening
tests. Ongoing research about this disease,
encouraging yearly screening and
education about the signs and symptoms of
cell change and cervical cancer are
important in decreasing the deaths related
to this cancer.
There are two main types of cervical
cancer. The first one, which accounts for
about 90% of diagnosed cervical cancers, is
squamous cell carcinoma that covers the
cervix (Peate & Jones, 2014, p. 51). The
second type of cervical cancer is located in
the gland cells of the endocervix that make
the mucus and this is called cervical
adenocarcinoma. According to the
American Cancer Society (2017), doctors
are seeing more cases of cervical
adenocarcinoma in the past 20 to 30 years.
Lastly, a less common form of cervical
cancer has features of both squamous cell
carcinomas and adenocarcinomas called
adenosquamous carcinomas or mixed
carcinomas.

Why should women care …
Why should women care about
cervical cancer? For one, it is one
of the cancers, if caught early,
that can be treated and cured.
Secondly, because most forms of
this cancer are caused by one or
more strains of HPV, it is likely
many women have already been
exposed to the virus and do not
realize it. Bogaards et. al (2010)
cite in their findings “most
women will contract at least 1
high-risk HPV infection during
their lifetime” (p. 823). Some
women will have strong enough
immune systems that can clear
the HPV infection and will never
have to face a cancer diagnosis.
Other women will hear those
scary three words, “You have
cancer” and their lives will
change. Empowering women
with the information on this
potentially deadly virus, how it
invades the female body, how it
causes cellular change and what
can be done to prevent it means
a healthier female population
worldwide and for generations to
come.

Signs &
Symptoms
•

•

•

•

•

Vaginal discharge with
unpleasant smell (Peate
& Jones, 2014, p. 535)
Bloody discharge
between periods or after
menopause (ACS, 2017)
Bleeding after vaginal
sex, bleeding or spotting
between periods or after
douching or pelvic exam
( ACS, 2017)
Bleeding after
menopause strong
indication of cervical
cellular change (Walker
& Hamilton, 2017, p. 6)
Pain during intercourse
(Walker & Hamilton,
2017, p. 6)

Significance of Pathophysiology
Knowing certain strains of the human papillomavirus cause about 90% of all
cervical cancers in women makes it easier for medical professionals to detect and treat
this type of cancer. Research shows there are two main effective ways to detect the
virus that can lead to treatment. The first is through cytology-based screening using
either conventional cervical cytology or Pap smears or a liquid-based cytology that
involves collecting cell samples from inside a woman’s cervix and then prepping those
cells on a slide, staining them, reading and reporting (Sherris, et al., 2009). The purpose
of this testing is to detect precursors of cervical cancer on the epithelial tissue and to
treat it before it progresses, Sherris, et al. (2009) also cite HPV DNA testing as another
option which uses cervical or vaginal samples obtained with a brush instead of a swab.
Their research shows this type of test is more effective in women over the age of 30
because this age group is at higher risk for precancerous lesions “because of the greater
likelihood that a positive test result at that age signals a persistent HPV infection”
leading to cancer (Sherris, et al., 2009, p. 149).

Recommendation

Grade

Women 21-65(Pap Smear)
or 30-65 (in combo with
HPV test)

Screen for cervical cancer
in ages 21-65 with Pap
smear evert 3 years.
Women 30-65 who want
to lengthen screening
interval, Pap Smear/HPV
testing every 5 years

A

Against screening for
cervical cancer with HPV
testing, alone or in combo
with Pap Smear in women
< 30

D

Women <21

Against screening for
cervical cancer

D

Women >65, had
adequate prior screening

Against screening for
cervical cancer/not high
risk

D

Women who have had a
hysterectomy

Against screening for
cervical cancer/no hx of
high grade
lesions/cervical cancer

D

Women <30, HPV testing

Nursing Implications
Cervical cancer was once one of the leading causes of
cancer deaths among women in the United States, but
according to the American Cancer Society (2017) those
numbers have been cut in half because of the increased use
of the Pap test. This screening allows advanced practitioners
to find changes in the cervix before it develops into cancer or
if it is already cancer, catch at an early, curable stage.
Research has shown that education on the HPV virus
and the need for early and continuous screening is important
in protecting against and treating cervical cancer. The U.S.
Preventive Task (2012) latest recommendation on screening
for women breaks down the population into five different
categories (see Appendix) for screening and prevention.
These are the most current recommendations available but
the U.S. Preventive Task force does say it is currently working
on updating these guidelines.
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Pathophysiology

The cervix, which is also known as the neck of the womb (Peate & Jones, 2014, p.
534) is located just below the uterus. The cervical canal is a narrow channel that goes
from the vagina to the inside of the uterus and normally stays closed except when a
woman has her menses letting blood flow from the uterus. It also opens to allow
sperm to travel inside and then has the ability to expand later on during labor and
birth.
The cervix has two types of cells that are the focus of cervical cancer. First, the
cervix is covered with skin-like cells or epithelial cells. Secondly, there are tiny glands
that line the cervical canal which make mucus and these cells can be susceptible to
change which can lead to cancer. Research has shown these changes come from the
human papillomavirus or HPV.
The human papillomavirus is a group of more than 200 related viruses with
more than 40 HPV types spread through direct sexual contact, skin to mucous
infections, vaginal, anal and oral sex (National Cancer Institute, 2015). The sexually
transmitted HPVs fall into two categories. Low-risk HPVs which are types 6 and 11
(National Cancer Institute, 2015), do not cause cancer but do cause genital warts.
There are about a dozen or so high-risk HPVs that can cause cancer but research
shows types 16 and 18 are responsible for most HPV-caused cancers (National Cancer
Institute, 2015).
HPV causes cancer by infecting the epithelial cells which line the cervix. Once
HPV enters the cells, the virus starts making proteins the interfere with cell function.
The National Cancer Institute (2015) identifies these proteins as E6 and E7 that help
the cell grow in an “uncontrolled manner and to avoid cell death” (para. 19). Choma
and McKeaver (2014) suggest differences in cell biology during various stages of a
female’s life can have an impact “on increasing exposure to the HPV virus” (p. 52).
They say during puberty the cervical transformation zone, which is where the
columnar cells meet the squamous cells, shift “outward onto the portio of the cervix”
and the columnar epithelium gradually changes into squamous epithelium which
ultimately supports HPV replication because the cells are replicating so fast (Choma &
McKeaver, 2014, p. 52).

Population

A second major implication for nursing includes the education and promotion of the
HPV vaccine Gardasil. de Sanjose et al (2017) cite HPV causing “virtually all cervical
cancer and its immediate precursors everywhere in the world” (p. 452) with HPV 16 and
HPV 18 subtypes associated with those cancers. Current research shows that by
vaccinating the female population “could reduce up to 90% of cervical cancer incidence
worldwide with the existing vaccines” (de Sanjose et al., 2017, p. 452). There are three
different prophylactic vaccines available with the latest one just released in May 2017.
The vaccines and guidelines are below (de Sanjose, 2017, p. 453):
Bivalent (16/18)
Quadrivalent (6,11,16, 18)
Nine-Valent (6,11, 16, 18, 31, 33, 45, 52, 58)
Girls vaccinated 9yrs to 14 years – two doses
Girls vaccinated 15 years over – three doses
Boys can be vaccinated following same ages as girls

Conclusion
While cervical cancer is not the killer among women it used to be, it is
still a concern among women ages 21 to 65. Most types of cervical
cancer are caused by the HPV virus. With the proper screening and
tests, APNs can detect changes in cervical cells before they become
invasive cancer. Along with proper screening, patients need to be
aware of the symptoms associated with this disease. Women must
understand the importance of bringing these symptoms and any
other changes they consider “out of the ordinary” to their APN’s
attention. Such vigilance can lead to catching the disease early, thus
avoiding invasive treatment and or possibly death.
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